Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	1,094	1,069	4,170	1,399	1,522	1,503
Depreciation & Amortization	160.9	156.6	155.2	144.9	139.6	134.8
Stock-Based Compensation	163.3	158.1	162.3	139.4	126.8	109.3
Other Adjustments	-1.45	56.5	-3,686	-261.6	-148.7	-160.4
Change in Receivables	-97.2	-23	121.2	-141.2	-84.1	-91.1
Changes in Inventories	49.2	50.7	-256.1	-289	-213.4	19
Changes in Accounts Payable	151.4	395.1	89.5	146	-21.4	195.2
Changes in Accrued Expenses	-89.8	-76.5	-36.8	-33	-45	-29.2
Changes in Income Taxes Payable	-151.1	-141.8	-186.7	-5.8	-5.6	62
Changes in Other Operating Activities	-67	-49.9	9.6	-203.3	-51.9	-10.6
Operating Cash Flow	1,359	1,595	542.3	895.8	1,218	1,732
Operating Cash Flow Growth	55.06%	194.16%	-39.46%	-26.46%	-29.67%	64.29%
Capital Expenditures	-269.1	-260.2	-252.4	-253	-244.6	-325.8
Purchases of Intangible Assets	-	-	-30	-13.3	-20.2	-4
Purchases of Investments	-3,167	-3,135	-945.8	-75.5	-669.3	-1,879
Proceeds from Sale of Investments	2,755	2,878	857.6	715.8	1,359	529.2
Payments for Business Acquisitions	-35.1	-	-1,062	-95.2	-	-
Proceeds from Business Divestments	-	42.5	3,927	-	-	-
Other Investing Activities	-214.5	-238.2	-182.1	-105	-172.7	-42.6
Investing Cash Flow	-891	-712.9	2,313	173.8	252.3	-1,723
Long-Term Debt Issued	-	-	-	-	-	5.2
Long-Term Debt Repaid	-	-	-	-	-	-7
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-	-1.8
Issuance of Common Stock	193.1	174.1	179.5	169.9	146.4	158.6
Repurchase of Common Stock	-1,107	-893.4	-1,159	-879.6	-1,727	-512.8
Net Common Stock Issued (Repurchased)	-913.5	-719.3	-979.9	-709.7	-1,581	-354.2
Other Financing Activities	-2.8	-237.5	-3.1	-1.3	-3.8	-0.3
Financing Cash Flow	-1,150	-956.8	-983	-711	-1,585	-356.3
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-18.9	-44.8	38.6	16.8	19.2	13.9
Net Cash Flow	-701.3	-119.3	1,911	375.4	-94.8	-332.8
Free Cash Flow	1,090	1,335	289.9	642.8	973.6	1,406
Free Cash Flow Growth	-18.39%	360.50%	-54.90%	-33.98%	-30.77%	117.26%
FCF Margin	17.28%	22.00%	5.33%	12.83%	21.81%	26.88%
Free Cash Flow Per Share	1.87	2.28	0.48	1.05	1.56	2.23
Levered Free Cash Flow	880.7	1,148	3,697	909.2	1,080	1,547
Unlevered Free Cash Flow	898.11	1,123	765.54	670.35	863.32	1,538

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q